Wanbury - Quaterly Results

15 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 1720.00 millions grew by 23.07 % from Rs. 1397.63 millions.The company almost doubled its revenue to Rs. 202.57 millions  from Rs. 80.76 millions in the quarter ended March 2025.The company reported a good operating profit of 314.71 millions compared to 190.88 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1720.00 1397.63 23.07 5995.14 5777.37 3.77 5995.14 5777.37 3.77
Other Income 18.44 5.68 224.65 34.93 9.02 287.25 34.93 9.02 287.25
PBIDT 314.71 190.88 64.87 798.13 729.93 9.34 798.13 729.93 9.34
Interest 90.42 74.60 21.21 369.51 291.81 26.63 369.51 291.81 26.63
PBDT 224.29 116.28 92.89 428.62 438.12 -2.17 428.62 438.12 -2.17
Depreciation 33.74 32.80 2.87 133.11 130.31 2.15 133.11 130.31 2.15
PBT 190.55 83.48 128.26 295.51 307.81 -4.00 295.51 307.81 -4.00
TAX -12.02 2.72 -541.91 -9.79 3.81 -356.96 -9.79 3.81 -356.96
Deferred Tax -70.63 2.72 -2696.69 -68.40 3.81 -1895.28 -68.40 3.81 -1895.28
PAT 202.57 80.76 150.83 305.30 304.00 0.43 305.30 304.00 0.43
Equity 327.71 327.46 0.08 327.71 327.46 0.08 327.71 327.46 0.08
PBIDTM(%) 18.30 13.66 33.97 13.31 12.63 5.37 13.31 12.63 5.37

Wanbury Share Price

230.60 3.45 (1.52%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×